InsidersTradesSigma
NA
NAN Stock: price and insider trades · Australia · ASX
Track the NAN stock price and the full management transaction log of the company, a publicly traded company based in Australia. Shares are quoted on AU AU, under the oversight of ASX. Operating in the Health Care sector, NAN has recorded 4 reports. Market capitalisation: €986.4m. The latest transaction was disclosed on 28 May 2026 (Initial Substantial Holding). Among the most active insiders: 2. Details of voting power. Every trade is openly available.
4
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate NAN Buy (bullish), based on 8 analysts. Average price target: A$4.30.
8Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 10,024 of 25,936 companies
57.8
score / 100
Value38
Quality78
FCF yld3.6%
Earn yld2.1%
EV/EBITDA31.2x
ROE10%
Gross mgn78%
Net mgn10%
Debt/EBITDA0.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 28 May 2026
Declarations4 total
ShareASXASX:2924-03094961-2A1674400
ShareASXASX:2924-03089787-2A1671937
ShareASXASX:2924-03089364-2A1671731
ShareASXASX:2924-03088867-2A1671500
4 of 4 declarations
About NAN
NAN is a company operating in the healthcare and pharmaceutical sector, listed on the XASX. It focuses on developing innovative solutions to enhance patient health.
